Blog

Viral load (VL) monitoring is being rapidly scaled up in resource-limited settings to help meet the UNAIDS 90-90-90 treatment goal of 73% viral suppression among all people living with HIV (PLHIV). Dried blood spots (DBS) make VL testing available to peripheral sites, however they have...

You are invited to attend the public defense of the thesis: Development and evaluation of a patient-centered cardiovascular health education program among insured primary care patients with hypertension in rural Nigeria – The QUICK-II study - by Aina Olufemi (Femi) Odusola on Wednesday 16th December at 16.00 hours   Agnietenkapel Oudezijds...

The work of AIGHD viro-immunologist Dr. Pascale Ondoa is highlighted in the latest ASLM newsletter pages 9-10.   “Before disaster strikes and a locally contained outbreak becomes a global epidemic, how can the international community work together to minimize loss of life and economic upheaval? Viro-immunologist Dr....

Frank Cobelens appointed chair of Executive Board at AIGHD   Prof. Frank Cobelens is appointed chair of the Executive Board at the Amsterdam Institute for Global Health and Development (AIGHD) as of 1 January 2016. Cobelens is linked to AIGHD and the AMC as professor of Epidemiology...

New results from the AGEhIV Cohort Study, investigating comorbidity and aging in HIV, were presented during an oral abstract session, jointly organized by the European AIDS Clinical Society (EACS) conference and the International Workshop on Co-morbidities and Adverse Drug Reactions in HIV in Barcelona, Spain...

Resistance to tuberculosis (TB) drugs is a major public health problem threatening progress made in TB control worldwide. In some European and Central Asian countries, over 15 % of new and 50 % of previously treated TB cases have multidrug-resistant tuberculosis (MDR-TB) that cannot be treated with...